{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:52:42Z","timestamp":1781952762169,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004206","name":"The University of Osaka","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10928-026-10028-9","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:12:06Z","timestamp":1774361526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of a physiologically-based pharmacokinetic model for investigating time-dependent variability in the fetal-to-maternal plasma concentration ratio of digoxin"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3907-5594","authenticated-orcid":false,"given":"Kanoko","family":"Okuba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-4464","authenticated-orcid":false,"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"6","key":"10028_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2165\/11597440-000000000-00000","volume":"51","author":"K Abduljalil","year":"2012","unstructured":"Abduljalil K, Furness P, Johnson TN, Rostami-Hodjegan A, Soltani H (2012) Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling. Clin Pharmacokinet 51(6):365\u2013396. https:\/\/doi.org\/10.2165\/11597440-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"10028_CR2","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40262-017-0618-1","volume":"57","author":"K Abduljalil","year":"2018","unstructured":"Abduljalil K, Johnson TN, Rostami-Hodjegan A (2018) Fetal physiologically-based pharmacokinetic models: systems information on fetal biometry and gross composition. Clin Pharmacokinet 57(9):1149\u20131171. https:\/\/doi.org\/10.1007\/s40262-017-0618-1","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10028_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40262-018-0685-y","volume":"58","author":"K Abduljalil","year":"2019","unstructured":"Abduljalil K, Jamei M, Johnson TN (2019) Fetal physiologically based pharmacokinetic models: systems information on the growth and composition of fetal organs. Clin Pharmacokinet 58(2):235\u2013262. https:\/\/doi.org\/10.1007\/s40262-018-0685-y","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10028_CR4","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.124.001824","volume":"53","author":"ZM Al-Majdoub","year":"2025","unstructured":"Al-Majdoub ZM, Freriksen JJM, Colbers A, van den Heuvel J, Koenderink J, Abduljalil K, Achour B, Barber J, Greupink R, Rostami-Hodjegan A (2025) Absolute membrane protein abundance of P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins in term human placenta tissue and commonly used cell systems: application in physiologically based pharmacokinetic modeling of placental drug disposition. Drug Metab Dispos 53(1):100007. https:\/\/doi.org\/10.1124\/dmd.124.001824","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10028_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","volume":"44","author":"GD Anderson","year":"2005","unstructured":"Anderson GD (2005) Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44(10):989\u20131008. https:\/\/doi.org\/10.2165\/00003088-200544100-00001","journal-title":"Clin Pharmacokinet"},{"key":"10028_CR6","unstructured":"ANMF: Australasian neonatal medicines formulary (2021) Digoxin newborn use only 2021. https:\/\/www.anmfonline.org\/wp-content\/uploads\/2021\/06\/digoxin-26042021-2.0.pdf. Accessed 17 Au 2025"},{"issue":"4","key":"10028_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/s0022-3476(05)81156-4","volume":"121","author":"A Azancot-Benisty","year":"1992","unstructured":"Azancot-Benisty A, Jacqz-Aigrain E, Guirgis NM, Decrepy A, Oury JF, Blot P (1992) Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias. J Pediatr 121(4):608\u2013613. https:\/\/doi.org\/10.1016\/s0022-3476(05)81156-4","journal-title":"J Pediatr"},{"key":"10028_CR8","volume-title":"Maternal, fetal and neonatal physiology: a clinical perspective","author":"S Blackburn","year":"2007","unstructured":"Blackburn S (2007) Maternal, fetal and neonatal physiology: a clinical perspective, 3rd edn. Saunders Elsevier, Philadelphia","edition":"3rd edn"},{"key":"10028_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000410667","volume":"13","author":"JC Challier","year":"1985","unstructured":"Challier JC (1985) Criteria for evaluating perfusion experiments and presentation of results. Contrib Gynecol Obstet 13:32\u201339","journal-title":"Contrib Gynecol Obstet"},{"issue":"3","key":"10028_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0022-3565(25)23138-X","volume":"256","author":"LO Derewlany","year":"1991","unstructured":"Derewlany LO, Leeder JS, Kumar R, Radde IC, Knie B, Koren G (1991) The transport of digoxin across the perfused human placental lobule. J Pharmacol Exp Ther 256(3):1107\u20131111","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10028_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/clpt.2008.1","volume":"84","author":"MF Hebert","year":"2008","unstructured":"Hebert MF, Easterling TR, Kirby B, Carr DB, Buchanan ML, Rutherford T, Thummel KE, Fishbein DP, Unadkat JD (2008) Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 84(2):248\u2013253. https:\/\/doi.org\/10.1038\/clpt.2008.1","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10028_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0301-2115(02)00513-4","volume":"109","author":"G Holcberg","year":"2003","unstructured":"Holcberg G, Sapir O, Tsadkin M, Huleihel M, Lazer S, Katz M, Mazor M, Ben-Zvi Z (2003) Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 109(2):133\u2013137. https:\/\/doi.org\/10.1016\/s0301-2115(02)00513-4","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"10028_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1253\/circj.cj-24-0073","volume":"89","author":"Y Iwasaki","year":"2025","unstructured":"Iwasaki Y, Noda T, Akao M, Fujino T, Hirano T, Inoue K, Kusano K, Nagai T, Satomi K, Shinohara T, Soejima K, Sotomi Y, Suzuki S, Yamane T, Kamakura T, Kato H, Katsume A, Kondo Y, Kuroki K, Makimoto H, Murata H, Oka T, Tanaka N, Ueda N, Yamasaki H, Yamashita S, Yasuoka R, Yodogawa K, Aonuma K, Ikeda T, Minamino T, Mitamura H, Nogami A, Okumura K, Tada H, Kurita T, Shimizu W, on behalf of the Japanese Circulation Society and Japanese Heart Rhythm Society Joint Working Group (2025) Guideline focused update on management of cardiac arrhythmias. Circ J 89(7):1012\u20131073. https:\/\/doi.org\/10.1253\/circj.cj-24-0073","journal-title":"Circ J"},{"key":"10028_CR14","unstructured":"JSPCCS: Japanese Society of Pediatric Cardiology and Cardiac Surgery (2021) Guidelines for fetal echocardiography, 2nd edn. http:\/\/jpccs.jp\/index.html?vol=37&no=s1. Accessed 17 Aug 2025"},{"issue":"3","key":"10028_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1124\/dmd.121.000648","volume":"50","author":"K Kurosawa","year":"2022","unstructured":"Kurosawa K, Noguchi S, Nishimura T, Tomi M, Chiba K (2022) Transplacental pharmacokinetic model of digoxin based on ex vivo human placental perfusion study. Drug Metab Dispos 50(3):287\u2013298. https:\/\/doi.org\/10.1124\/dmd.121.000648","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10028_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/17512433.2017.1344096","volume":"10","author":"A Martin-Suarez","year":"2017","unstructured":"Martin-Suarez A, Sanchez-Hernandez JG, Medina-Barajas F, P\u00e9rez-Blanco JS, Lanao JM, Garcia-Cuenllas Alvarez L, Calvo MV (2017) Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia. Expert Rev Clin Pharmacol 10(8):911\u2013917. https:\/\/doi.org\/10.1080\/17512433.2017.1344096","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"10","key":"10028_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.placenta.2004.04.011","volume":"25","author":"TM Mayhew","year":"2004","unstructured":"Mayhew TM, Wijesekara J, Baker PN, Ong SS (2004) Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta 25(10):829\u2013833. https:\/\/doi.org\/10.1016\/j.placenta.2004.04.011","journal-title":"Placenta"},{"key":"10028_CR18","unstructured":"MHLW (2024) Ministry of health, labour and welfare. The bulletin which revises the part of the calculation method of a medical service fee. https:\/\/www.mhlw.go.jp\/content\/12404000\/001251499.pdf. Accessed 17 Aug 2025"},{"issue":"7","key":"10028_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jacc.2019.06.024","volume":"74","author":"T Miyoshi","year":"2019","unstructured":"Miyoshi T, Maeno Y, Hamasaki T, Inamura N, Yasukochi S, Kawataki M, Horigome H, Yoda H, Taketazu M, Nii M, Hagiwara A, Kato H, Shimizu W, Shiraishi I, Sakaguchi H, Ueda K, Katsuragi S, Yamamoto H, Sago H, Ikeda T, Japan Fetal Arrhythmia Group (2019) Antenatal therapy for fetal supraventricular tachyarrhythmias: multicenter trial. J Am Coll Cardiol 74(7):874\u2013885. https:\/\/doi.org\/10.1016\/j.jacc.2019.06.024","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10028_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/14767050802073790","volume":"21","author":"D Patel","year":"2008","unstructured":"Patel D, Cuneo B, Viesca R, Rassanan J, Leshko J, Huhta J (2008) Digoxin for the treatment of fetal congestive heart failure with sinus rhythm assessed by cardiovascular profile score. J Matern Fetal Neonatal Med 21(7):477\u2013482. https:\/\/doi.org\/10.1080\/14767050802073790","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10028_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","volume":"24","author":"MM Rhodin","year":"2009","unstructured":"Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, Chatelut E, Grubb A, Veal GJ, Keir MJ, Holford NHG (2009) Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 24(1):67\u201376. https:\/\/doi.org\/10.1007\/s00467-008-0997-5","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10028_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031848","volume":"24","author":"N Starodubtseva","year":"2023","unstructured":"Starodubtseva N, Kindysheva S, Potapova A, Kukaev E, Khodzhaeva Z, Bockeria E, Chagovets V, Frankevich V, Sukhikh G (2023) Transplacental therapeutic drug monitoring in pregnant women with fetal tachyarrhythmia using HPLC-MS\/MS. Int J Mol Sci 24(3):1848. https:\/\/doi.org\/10.3390\/ijms24031848","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10028_CR23","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1023\/a:1025049014674","volume":"20","author":"MD Troutman","year":"2003","unstructured":"Troutman MD, Thakker DR (2003) Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. Pharm Res 20(8):1200\u20131209. https:\/\/doi.org\/10.1023\/a:1025049014674","journal-title":"Pharm Res"},{"issue":"2","key":"10028_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.dmpk.2014.11.002","volume":"30","author":"Y Uchida","year":"2015","unstructured":"Uchida Y, Ohtsuki S, Kamiie J, Ohmine K, Iwase R, Terasaki T (2015) Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks. Drug Metab Pharmacokinet 30(2):205\u2013208. https:\/\/doi.org\/10.1016\/j.dmpk.2014.11.002","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"10028_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sj.jp.7211290","volume":"25","author":"MA Underwood","year":"2005","unstructured":"Underwood MA, Gilbert WM, Sherman MP (2005) Amniotic fluid: not just fetal urine anymore. J Perinatol 25(5):341\u2013348. https:\/\/doi.org\/10.1038\/sj.jp.7211290","journal-title":"J Perinatol"},{"issue":"11","key":"10028_CR26","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3109\/14767058.2011.554924","volume":"24","author":"K Zhou","year":"2011","unstructured":"Zhou K, Hua Y, Zhu Q, Liu H, Yang S, Zhou R, Guo N (2011) Transplacental digoxin therapy for fetal tachyarrhythmia with multiple evaluation systems. J Matern Fetal Neonatal Med 24(11):1378\u20131383. https:\/\/doi.org\/10.3109\/14767058.2011.554924","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10028-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10028-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10028-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:41:42Z","timestamp":1781952102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-026-10028-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10028"],"URL":"https:\/\/doi.org\/10.1007\/s10928-026-10028-9","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve human participants or animals.Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"This study did not involve human participants; therefore, informed consent was not required.Clinical trial number: not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"18"}}